Escagen Corp said an initialoffering of two mln common shares is underway at nine dlrs eachthrough underwriters led by &lt;Prudential-Bache Group Inc>.    The company is purchasing the assets and business ofInternational Plant Research Institute and will apply plantbiotechnology to developing food products and plantingmaterials. Reuter&#3;